Categories: BusinessChemicalDrugHumanIndustryLifePlatform
Leadart Technologies is a biomedical company based on novel and high-throughput chemical proteomic platform. Leadart Technologies is focused on accelerating industrial and academic therapeutic innovation to improve human life. We are committed to become the industrial leader in the new era of drug and target discovery. The Leadart Technologies team attended the First Oversea Scholar Startup Competition held in Xiaoshan, Zhejiang, China in December, 2016. Over 30 scholars from oversea participated this competition, and Leadart Technologies team won the ‘Best Business Model Award’.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 02.01.2023 | - | $6M | - |
Mentions in press and media 4
| Date | Title | Description |
| 02.01.2023 | LeadArt Biotechnologies Completes US$6M Pre-A Financing | LeadArt Biotechnologies, a Boston, MA and Ningbo, China-based biotechnology company focused on drug discovery by automating chemoproteomics processes, raised US$6M in Pre-A funding.
The round was led by BlueRun Ventures Aster.
The company i... |
| 27.12.2022 | LeadArt Biotechnologies Closes US$6M Pre-A Financing to Advance Automated Chemoproteomics Platform and Business Collaboration | – Global technology company focused on discovering disease-related targets and chemical probes for traditionally undruggable and unexplored targets – Pre-A financing round led by BlueRun Ventures Aster
LeadArt Biotechnologies, a company aim... |
| 27.12.2022 | LeadArt Biotechnologies Closes US$6M Pre-A Financing to Advance Automated Chemoproteomics Platform and Business Collaboration | Feng Ni, PhD, co-founder and Chief Executive Officer, LeadArt Biotechnologies, said, “We are excited to leverage this funding to move aggressively in the development of our innovative technologies and external business collaborations."... |
| - | Leadart Technologies | “LeadArt Biotechnologies” |
Reviews 0
